Floatz logo

Angiotensin Ii

Disease Related To Solid Organ Transplantation

University of California, San Franciscoprotein_peptidePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Disease Related To Solid Organ Transplantation cohort.

Asset / SponsorPhaseRating
TACROLIMUS
The Second Hospital of Tangshan
Phase 4BBB
Everolimus
Novartis Pharmaceuticals
Phase 3BB
Equine Atg
University Hospital, Toulouse
Phase 4BB
Envarsus Product
University of Alberta
Phase 4BB
Sitagliptin
University Health Network, Toronto
Phase 4BB

View all 34 →

Same molecule, other indications

Angiotensin Ii is also rated in:

acute kidney injuryActive
BB
Indicative · Phase 4
70 / 100
View asset →
cirrhosis of liverActive
BB
Indicative · Phase 4
67 / 100
View asset →
chronic liver failureActive
BB
Indicative · Phase 4
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →